Open AccessSafety, Efficacy, and Drug Survival of Colchicine in Recurrent Aphthous Stomatitis in a Real-World Setting
Author(s) -
Jongwook Oh,
Jae-Won Lee,
Kyung Bae Chung,
Dongsik Bang,
Doyoung Kim
Publication year - 2022
Publication title -
annals of dermatology/annals of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.385
H-Index - 37
eISSN - 2005-3894
pISSN - 1013-9087
DOI - 10.5021/ad.2022.34.1.22
Subject(s) - medicine , discontinuation , colchicine , adverse effect , stomatitis , neutropenia , drug , recurrent aphthous stomatitis , retrospective cohort study , adverse drug reaction , surgery , gastroenterology , chemotherapy , pharmacology
Recurrent aphthous stomatitis (RAS) is a common disorder characterized by episodic ulcerations in the oral mucosa. Although colchicine has been a common systemic treatment for RAS, there is still considerable uncertainty regarding its efficacy and drug survival in this setting.